CS Group (OTCQB: CSDX) has appointed Shah Teelani & Associates, a Dubai-based audit firm registered with the Public Company Accounting Oversight Board (PCAOB), to consolidate and audit all 2025 financial statements for the company and its international subsidiaries. This engagement represents a strategic move to strengthen financial governance and transparency as the medical technology company expands operations across the United States, GCC region, and Europe.
The consolidated audit will encompass financial statements for CS Diagnostics Corp. (OTCQB: CSDX), CS Interpharm GT LLC, and CS Diagnostics Pharma GmbH. Management stated that appointing a PCAOB-registered audit firm aligns the Group's financial reporting structure with U.S. public company standards while integrating its growing international companies under a unified reporting framework. The 2025 consolidated financial review will include operations related to the MEDUSA hygiene and disinfectant platform and international distribution expansion.
"Engaging Shah Teelani & Associates as our PCAOB-registered auditor represents an important milestone in CS Group's evolution as a publicly traded company," said Mohammad Essayed, Group Chief Financial Officer. "As we scale operations across multiple regions, it is essential that our financial reporting structure reflects institutional-grade standards, transparency, and regulatory compliance. This appointment strengthens our governance foundation and supports our long-term growth strategy."
The appointment comes as CS Group continues to focus on expanding manufacturing partnerships, regulatory positioning, international distribution agreements, and capital markets readiness as part of its broader global growth roadmap. The company's portfolio includes MEDUSA, a smart disinfectant and hygiene solutions platform expanding into wet wipes and liquid formulations for institutional and consumer use, and CS Protect-Hydrogel, a tissue spacer designed to protect healthy organs during prostate cancer radiotherapy.
This move toward consolidated financial reporting with a PCAOB-registered auditor is significant for investors and stakeholders as it enhances financial clarity, streamlines reporting processes, and strengthens investor confidence in a company operating across multiple international jurisdictions. The consolidation of financial statements across all entities provides a more comprehensive view of the company's global operations and financial health, which is particularly important as CS Group progresses through key commercialization milestones including strategic manufacturing partnerships and multi-region launches. For further information, please visit https://group-csd.com/.
